港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

药捷安康-B

53.150

-0.600-1.12%

成交量：26.56万

成交额：1,368.29万

市值：210.95亿

市盈率：-67.77

高：54.050

开：52.750

低：48.660

收：53.750

52周最高：58.050

52周最低：20.200

股本：3.97亿

香港流通股本：3.02亿

量比：1.46

换手率：0.09%

股息：- -

股息率：- -

每股收益(LYR):-0.784

净资产收益率：-41.98%

总资产收益率：-24.05%

市净率：36.86

市盈率(LYR):-67.77

市销率: - -

数据加载中...

总览公司新闻公告

中信证券保荐生物科技领先公司药捷安康成功登陆港交所

中信证券发布

药捷安康登陆港交所为今年南京江北新区首家上市企业

药捷安康-B上市首日盘中涨幅扩大至80%，中签一手赚超5000港元

老虎资讯综合

“60后”博士四闯港交所，小分子Biotech开局大涨70%

动脉新医药

异动解读 | 药捷安康-B上市首日大涨63%，创新药研发引爆投资热情

异动解读 | 药捷安康-B上市首日大涨63%，IPO超额认购3420倍

新股首日｜药捷安康-B飙涨超64%，佰泽医疗涨超24%，三花智控破发开跌7%

老虎资讯综合

新股定价 | 药捷安康-B每股定价13.15港元，公开发售超购近3419倍，一手中签率0.8%

老虎资讯综合

《新股》药捷安康(02617.HK)公开发售超购近3,419倍一手中签仅0.8%

阿斯达克财经

药捷安康-B(02617)香港公开发售获3419.87倍认购预期6月23日上市

老虎暗盘 | 药捷安康-B大涨近60%，每手赚近4000港元

老虎资讯综合

三花智控(02050)、佰泽医疗(02609)、药捷安康-B(02617)已获接纳在中央结算系统内进行结算、交收及提存

一周港股IPO：银诺医药等11家公司递表，药捷安康等8家通过聆讯

【券商聚焦】国元国际：美国债市收益率下跌，关注新股市场

新股招股 | 药捷安康-B 6月13日至6月18日招股，入场费6641.31港元，引入江北医药、康方生物科技等多位基石投资者

老虎资讯综合

药捷安康-B6月13日至6月18日招股拟全球发售1528.1万股H股

药捷安康全球发售计划启动 6月23日香港联交所上市

药捷安康-B(02617)6月13日至6月18日招股拟全球发售1528.1万股H股引入江北医药、康方生物科技等多位基石投资者

药捷安康全球发售计划启动 6月23日香港联交所上市

药捷安康-B(02617.HK)预计6月23日上市引入康方生物等多家基石

格隆汇资讯

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02617/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"药捷安康-B","latestPrice":53.15,"timestamp":1756194178093,"preClose":53.75,"halted":0,"volume":265580,"delay":0,"floatShares":301666673,"shares":396897633,"eps":-0.7842815634688939,"marketStatus":"交易中","change":-0.6,"latestTime":"08-26 15:44:00","open":52.75,"high":54.05,"low":48.66,"amount":13682917,"amplitude":0.100279,"askPrice":53.3,"askSize":2500,"bidPrice":53.05,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.7842815634688939,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1756195800000},"marketStatusCode":2,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":53.75,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":1.455069,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":301666673,"roa":"-24.05%","roe":"-41.98%","lyrEps":-0.784282,"volumeRatio":1.455069,"shares":396897633,"dividePrice":0,"high":54.05,"amplitude":0.100279,"preClose":53.75,"low":48.66,"week52Low":20.2,"pbRate":"36.86","week52High":58.05,"institutionHeld":0,"latestPrice":53.15,"committee":-0.666667,"eps":-0.7842815634688939,"divideRate":0,"volume":265580,"delay":0,"ttmEps":-0.7842815634688939,"open":52.75,"prevYearClose":13.15,"prevWeekClose":54.75,"prevMonthClose":37.95,"prevQuarterClose":30.15,"fiveDayClose":51.7,"twentyDayClose":40.9,"sixtyDayClose":13.15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2025-08-25","current":-71.114754,"percent":0.066667,"low":-72.789898,"twenty":-63.292817,"median":-44.380409,"eighty":-39.630155,"high":-17.403134,"avg":-49.174295,"sd":13.084245,"marketCap":21333247773},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-25","current":-71.114754,"twenty":-63.292817,"median":-44.380409,"eighty":-39.630155,"marketCap":21333247773}],"updateTime":1756186957066},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2545412373","title":"中信证券保荐生物科技领先公司药捷安康成功登陆港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2545412373","media":"中信证券发布","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545412373?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 20:34","pubTimestamp":1750682096,"startTime":"0","endTime":"0","summary":"2025年6月23日，中信证券作为联席保荐人、联席整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人，助力药捷安康（南京）科技股份有限公司成功于港交所主板上市，发行规模约2.0亿港币。中信证券全球投资银行管理委员会联席主任程杰出席上市仪式。本项目是中信证券推动服务创新型生物医药行业的又一典型案例。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623204753a718d6f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623204753a718d6f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06030","BK1516","02617","LU1794554557.SGD","LU1720050803.USD","BK1521","BK1147","BK1564"],"gpt_icon":1},{"id":"2545046731","title":"药捷安康登陆港交所 为今年南京江北新区首家上市企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2545046731","media":"e公司","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545046731?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 14:04","pubTimestamp":1750658640,"startTime":"0","endTime":"0","summary":"在公司负责人看来，诸多力量中，南京江北新区的支持是药捷安康顺利上市背后一支关键“助推剂”。药捷安康相关负责人说。“除了作为基石投资人投资药捷安康港股上市外，该只境外上市产业投资基金正在与新区另外几家计划境外上市企业对接。”","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623140543a4b850bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"03e355b77ba35e6757abcf8175791b1c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623140543a4b850bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617"],"gpt_icon":1},{"id":"1184639598","title":"药捷安康-B上市首日盘中涨幅扩大至80%，中签一手赚超5000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1184639598","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184639598?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 10:53","pubTimestamp":1750647238,"startTime":"0","endTime":"0","summary":"6月23日，$药捷安康-B(02617)$上市首日盘中涨幅扩大至80%，中签一手赚超5000港元，总市值超94亿港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c865ffc5b7b68e9a4882237735918ecc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2545946896","title":"“60后”博士四闯港交所，小分子Biotech开局大涨70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545946896","media":"动脉新医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545946896?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 10:03","pubTimestamp":1750644208,"startTime":"0","endTime":"0","summary":"2016年11月，吴永谦收购了药捷安康40%股权，并担任公司董事长。招股书显示，Tinengotinib是全球首个且唯一已进入注册临床阶段治疗FGFR抑制剂复发或难治性CCA患者的研究药物。在mCRPC领域，全球患者的五年生存率低于30%。直至截止日期2023年9月26日，350名实体瘤患者接受Tinengotinib单一疗法治疗，包括295名美国患者及55名中国患者。汇总安全性及耐受性数据显示，实体瘤患者对Tinengotinib耐受良好。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623101846a717e6a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623101846a717e6a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSTECH","02617"],"gpt_icon":1},{"id":"1135221454","title":"异动解读 | 药捷安康-B上市首日大涨63%，创新药研发引爆投资热情","url":"https://stock-news.laohu8.com/highlight/detail?id=1135221454","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135221454?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 09:34","pubTimestamp":1750642469,"startTime":"0","endTime":"0","summary":"6月23日，生物制药公司药捷安康-B在港交所主板挂牌上市，股价表现亮眼。开盘即大涨63.12%，报21.45港元，展现出投资者对这家创新药企的强烈兴趣。药捷安康是一家专注于肿瘤、炎症及心脏代谢疾病小分子创新疗法的生物制药公司。此次IPO，药捷安康发行1528.1万股H股，每股发售价13.15港元，募集资金净额约1.61亿港元。药捷安康的成功上市不仅反映了投资者对生物医药行业的持续看好，也凸显了市场对具有创新能力和强大研发实力的企业的青睐。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c865ffc5b7b68e9a4882237735918ecc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02617"],"gpt_icon":1},{"id":"1192489379","title":"异动解读 | 药捷安康-B上市首日大涨63%，IPO超额认购3420倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1192489379","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192489379?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 09:34","pubTimestamp":1750642447,"startTime":"0","endTime":"0","summary":"6月23日，生物制药公司药捷安康-B在港交所主板挂牌上市，股价表现强劲。盘中，该股大涨63.12%，引发市场广泛关注。药捷安康-B此次IPO反应热烈。公司公开发售部分获得约3420倍超额认购，显示投资者对其前景充满信心。作为一家专注于小分子创新药物开发的公司，药捷安康主要致力于肿瘤、炎症及心脏代谢疾病领域的治疗。投资者看好公司在生物制药领域的创新能力和市场潜力，推动其股价在上市首日大幅上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c865ffc5b7b68e9a4882237735918ecc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02617"],"gpt_icon":0},{"id":"1133456971","title":"新股首日｜药捷安康-B飙涨超64%，佰泽医疗涨超24%，三花智控破发开跌7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133456971","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133456971?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 09:23","pubTimestamp":1750641828,"startTime":"0","endTime":"0","summary":"6月23日，港股三只新股正式挂牌港交所，药捷安康-B飙涨超64%，公开发售获逾3400倍认购；佰泽医疗涨超24%，公开发售获近26倍认购；三花智控跌超7%。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c865ffc5b7b68e9a4882237735918ecc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02609","LU0359202008.SGD","LU2238339852.HKD","LU1328615791.USD","BK0070","LU2298064838.USD","LU2580892789.USD","02050","BK0187","LU1969619763.USD","LU2580892862.HKD","LU1023057109.AUD","002050","159891","LU0359201612.USD","LU1064130708.USD","BK0188","SGXZ49509284.SGD","02617","BK0028","LU2328871848.SGD","BK0197","BK0076"],"gpt_icon":0},{"id":"1136986243","title":"新股定价 | 药捷安康-B每股定价13.15港元，公开发售超购近3419倍，一手中签率0.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136986243","media":"老虎资讯综合","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136986243?lang=zh_cn&edition=fundamental","pubTime":"2025-06-23 07:51","pubTimestamp":1750636291,"startTime":"0","endTime":"0","summary":" $药捷安康-B(02617)$ (02617.HK)公布招股结果，公司全球发售15,281,000股H股，每股H股13.15港元，所得款项净额1.6亿港元。香港公开发售接获3,419.87倍认购，一手(500股)中签率0.8%。国际发售录得0.97倍认购。经重新分配，公开发售股份已增加至305.7万股，占发售总数20%。股份预期今日(23日)挂牌。五名基石投资者江北医药、康方生物、华盛敦行、药石地平线及科瓴安合共认购1.3亿元公司股份。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/651cc17f66c60995aacb866f4503fece","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/651cc17f66c60995aacb866f4503fece"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c865ffc5b7b68e9a4882237735918ecc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"新股定价 | 药捷安康-B每股定价13.15港元，公开发售超购近3419倍，一手中签率0.8%","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2545432833","title":"《新股》药捷安康(02617.HK)公开发售超购近3,419倍  一手中签仅0.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545432833","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545432833?lang=zh_cn&edition=fundamental","pubTime":"2025-06-22 19:55","pubTimestamp":1750593300,"startTime":"0","endTime":"0","summary":"药捷安康－Ｂ(02617.HK)公布招股结果，香港公开发售接获3,419.87倍认购，一手(500股)中签率0.8%。国际发售录得0.97倍认购。经重新分配，公开发售股份已增加至305.7万股，占发售总数20%。股份预期周一(23日)挂牌。生物制药公司药捷安康是次全球发售1,528.1万股，公开发售占10%。招股价13.15元，集资净额1.61亿元。五名基石投资者江北医药、康方生物(09926.HK) 华盛敦行、药石地平线及科瓴安合共认购1.3亿元公司股份。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-06-20 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250613105253140_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250613105253140_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1448313/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02617"],"gpt_icon":0},{"id":"2544750701","title":"药捷安康-B(02617)香港公开发售获3419.87倍认购 预期6月23日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2544750701","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544750701?lang=zh_cn&edition=fundamental","pubTime":"2025-06-20 22:54","pubTimestamp":1750431275,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药捷安康-B(02617)公布配发结果，公司全球发售1528.1万股H股股份，香港公开发售占20%，国际发售占80%。每股发售价13.15港元，全球发售净筹约1.61亿港元。每手 500 股 ，预期 H 股将于 2025 年 6 月 23 日(星期一)上午九时正(香港时间)在联交所开始买卖。其中，香港公开发售获3419.87倍认购，国际发售获0.97倍认购。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1308056.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02617"],"gpt_icon":0},{"id":"1158628026","title":"老虎暗盘 | 药捷安康-B大涨近60%，每手赚近4000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158628026","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158628026?lang=zh_cn&edition=fundamental","pubTime":"2025-06-20 16:16","pubTimestamp":1750407404,"startTime":"0","endTime":"0","summary":"本周五港股盘后， $药捷安康-B(02617)$ 暗盘大涨近60%，每手赚近4000港元：","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c865ffc5b7b68e9a4882237735918ecc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"老虎暗盘 | 药捷安康-B大涨近60%，每手赚近4000港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2544148220","title":"三花智控(02050)、佰泽医疗(02609)、药捷安康-B(02617)已获接纳在中央结算系统内进行结算、交收及提存","url":"https://stock-news.laohu8.com/highlight/detail?id=2544148220","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544148220?lang=zh_cn&edition=fundamental","pubTime":"2025-06-20 14:53","pubTimestamp":1750402406,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，6月19日，香港中央结算有限公司发布通告称，三花智控(02050)、佰泽医疗(02609)、药捷安康-B(02617)已获接纳在中央结算系统内进行结算、交收及提存。自2025年6月20日起，该等证券在联交所的买卖将透过中央结算系统进行结算；并于2025年6月23日起透过中央结算系统自动以持续净额交收制度进行交收。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"cbbb61f0deb5df3f9d66eb1cdedfdc0a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1307651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02609","LU2580892862.HKD","LU2328871848.SGD","002050","SGXZ81163826.USD","LU1939255532.USD","LU1969619763.USD","LU2148510915.USD","BK0197","LU2580892789.USD","LU1064130708.USD","SGXZ49509284.SGD","LU0359201612.USD","LU1064131003.USD","LU2298064838.USD","BK0028","02050","LU1023057109.AUD","02617","BK0259","BK0187","LU1328615791.USD","BK0070","LU2238339852.HKD","BK0076","LU0359202008.SGD","BK0188"],"gpt_icon":0},{"id":"2543467404","title":"一周港股IPO：银诺医药等11家公司递表，药捷安康等8家通过聆讯","url":"https://stock-news.laohu8.com/highlight/detail?id=2543467404","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543467404?lang=zh_cn&edition=fundamental","pubTime":"2025-06-16 19:49","pubTimestamp":1750074540,"startTime":"0","endTime":"0","summary":"据港交所披露，上周共有11家公司递表，8家公司通过聆讯，另有4家公司招股，及3只新股上市。11家公司递表1）广州银诺医药集团股份有限公司6月9日，银诺医药再次向港交所递交上市申请，中信证券、中金公司担任其联席保荐人。据招股书披露，东阳光药业是一家综合性制药公司，主要从事药物的研发、生产和商业化。截至最后实际可行日期，公司在中国销售48款药物，并在海外市场销售23款药物。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-06-16/doc-infahqxy2950297.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-06-16/doc-infahqxy2950297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4614","159938","BK1161","BK1515","YANG","09939","HSCEI","HSTECH","02617","BK1574"],"gpt_icon":1},{"id":"2543578068","title":"【券商聚焦】国元国际：美国债市收益率下跌，关注新股市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2543578068","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543578068?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 10:46","pubTimestamp":1749782809,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国元国际发布研报指，美国5月核心PPI同比+3%、环比+0.1%，均不及预期；上周初请失业金人数为24.8万高于预期。美国商务部宣布将自6月23日起对多种钢制家用电器加征关税。美国5月海运进口骤降，印度航空一架波音787客机坠毁，英国经济出现18个月来最严重萎缩。研报指出，2年期美债收益率跌5个基点报3.897%，5年期美债收益率跌5.6个基点报3.961%，10年期美债收益率跌6.11个基点报4.359%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1960417","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","09141","02609","02050"],"gpt_icon":0},{"id":"1199099806","title":"新股招股 | 药捷安康-B 6月13日至6月18日招股，入场费6641.31港元，引入江北医药、康方生物科技等多位基石投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=1199099806","media":"老虎资讯综合","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199099806?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 08:48","pubTimestamp":1749775685,"startTime":"0","endTime":"0","summary":"$药捷安康－Ｂ$于2025年6月13日至6月18日招股，拟全球发售1528.1万股H股，其中香港发售占约10%，国际发售占约90%，另有15%超额配股权。每股发售价13.15港元，每手500股，入场费6041.31港元，公司的H股将于2025年6月23日上午九时正开始在香港联交所买卖。按每股股份发售价为13.15港元计算且假设超额配股权并无获行使，经扣除集团就全球发售应付的包销费用及佣金以及估计费用后，集团估计将获得约1.61亿港元的所得款项净额。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/060a55041cf00c3335e5006f9e663b00","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/060a55041cf00c3335e5006f9e663b00"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3638bca7e36188f126db895b5930c5ee","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"新股招股 | 药捷安康-B今起招股，入场费6041.31港元","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":1},{"id":"2543526538","title":"药捷安康-B6月13日至6月18日招股 拟全球发售1528.1万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2543526538","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543526538?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 08:06","pubTimestamp":1749773160,"startTime":"0","endTime":"0","summary":"药捷安康-B于2025年6月13日至6月18日招股，拟全球发售1528.1万股H股，其中香港发售占约10%，国际发售占约90%，另有15%超额配股权。每股发售价13.15港元，每手500股，公司的H股将于2025年6月23日上午九时正开始在香港联交所买卖。进一步借助对转化医学及药物设计的深入研究，集团旨在开发具有战略意义的同类首创或同类最佳候选药物，以满足全球范围内的迫切临床需求。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3638bca7e36188f126db895b5930c5ee","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggipo/2025-06-13/doc-inezwrzm7429466.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02617"],"gpt_icon":0},{"id":"2543525470","title":"药捷安康全球发售计划启动 6月23日香港联交所上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2543525470","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543525470?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 07:56","pubTimestamp":1749772574,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K1TTHKVF0519QIKK.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"3638bca7e36188f126db895b5930c5ee","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K1TTHKVF0519QIKK.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02617"],"gpt_icon":0},{"id":"2543936525","title":"药捷安康-B(02617)6月13日至6月18日招股 拟全球发售1528.1万股H股 引入江北医药、康方生物科技等多位基石投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2543936525","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543936525?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 07:47","pubTimestamp":1749772057,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药捷安康-B 于2025年6月13日至6月18日招股，拟全球发售1528.1万股H股，其中香港发售占约10%，国际发售占约90%，另有15%超额配股权。按每股股份发售价为13.15港元计算且假设超额配股权并无获行使，经扣除集团就全球发售应付的包销费用及佣金以及估计费用后，集团估计将获得约1.61亿港元的所得款项净额。集团预计在2026年下半年完成患者入组。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3638bca7e36188f126db895b5930c5ee","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1304753.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BPRC5H50.USD","IE00B5MMRT66.SGD","BK1515","BK1574","LU0348783233.USD","IE00B543WZ88.USD","LU2488822045.USD","02617","LU0348784397.USD","LU1794554557.SGD","09939","159938","LU1720050803.USD","LU0417516571.SGD","09926","BK1161"],"gpt_icon":0},{"id":"2543525386","title":"药捷安康全球发售计划启动 6月23日香港联交所上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2543525386","media":"观点机构","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543525386?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 07:35","pubTimestamp":1749771306,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K1TSATVG0519D45U.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"3638bca7e36188f126db895b5930c5ee","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K1TSATVG0519D45U.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02617"],"gpt_icon":0},{"id":"2543523067","title":"药捷安康-B(02617.HK)预计6月23日上市 引入康方生物等多家基石","url":"https://stock-news.laohu8.com/highlight/detail?id=2543523067","media":"格隆汇资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543523067?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 07:28","pubTimestamp":1749770890,"startTime":"0","endTime":"0","summary":"格隆汇6月13日丨药捷安康-B发布公告，公司拟全球发售1528.1万股H股，中国香港发售股份152.85万股，国际发售股份1375.25万股，另有15%的超额配股权；2025年6月13日至6月18日招股；发售价将为每股发售股份13.15港元，每手买卖单位为500股，中信证券及华泰国际为联席保荐人；预期股份将于2025年6月23日开始在联交所买卖。按每股股份发售价为13.15港元计算且假设超额配股权并无获行使，集团估计将获得约1.613亿港元的所得款项净额。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613072818951a1c32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"3638bca7e36188f126db895b5930c5ee","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613072818951a1c32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1720050803.USD","IE00BPRC5H50.USD","BK1161","02617","IE00B543WZ88.USD","09926","LU0417516571.SGD","BK1574","LU0348783233.USD","LU1794554557.SGD","IE00B5MMRT66.SGD","LU0348784397.USD","LU2488822045.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":65,"code":"91000000","status":"200"}]}}